Bal Pharma Ltd. | Income Statement
Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Sales/Revenue
1,734
1,825
1,948
2,245
2,118
Cost of Goods Sold (COGS) incl. D&A
1,374
1,517
1,605
1,819
1,533
Gross Income
360
308
343
426
584
SG&A Expense
278
247
284
381
479
Unusual Expense
-
-
3
1
-
Non Operating Income/Expense
45
7
10
26
16
Interest Expense
71
64
65
82
93
Pretax Income
66
47
26
24
29
Income Tax
16
12
24
31
25
Consolidated Net Income
51
36
3
7
4
Net Income After Extraordinaries
51
36
14
20
4
Net Income Available to Common
51
36
14
20
4
EPS (Basic)
4.77
2.83
1.09
1.41
0.10
Basic Shares Outstanding
11
13
13
14
-
EPS (Diluted)
4.60
2.80
1.09
1.41
-
Diluted Shares Outstanding
11
13
13
14
-
EBITDA
138
172
151
141
174
Other Operating Expense
8
41
22
32
-
Non-Operating Interest Income
2
3
3
3
-
Minority Interest Expense
-
1
11
27
-
Other After Tax Income (Expense)
-
-
-
-
-
About Bal Pharma
View Profile
